Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Jing-Qiang Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2061-9551; OpenAlex author ID A5063540842. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma. Last author DOI 10.1177/03000605231218559↗
  2. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angioge… Co-author DOI 10.3892/mmr.2015.4158↗
  3. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression. Co-author DOI 10.3892/ijo.2014.2500↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingjing Zou · 1 shared paper, 2024 · strength 0.28
  2. Hongfei Tong · 2 shared papers, 2014–2015 · strength 0.09
  3. Zhaohong Wang · 2 shared papers, 2014–2015 · strength 0.09
  4. Sheng‐Zhang Lin · 1 shared paper, 2015 · strength 0.05
  5. Hui Chen · 1 shared paper, 2014 · strength 0.04
  6. Liang Chen · 1 shared paper, 2014 · strength 0.04
  7. Shengzhang Lin · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.